These results and literature may suggest that the inhibition of angiogenesis by CA may not be influenced by the downregulation of CD82, and rather by an alternative mechanism, such as the down regulation of VEGF, as angiogenesis was inhibited at both concentrations. This evidence concerns the gene CD82 and cancer.